Success Metrics

Clinical Success Rate
50.0%

Based on 3 completed trials

Completion Rate
50%(3/6)
Active Trials
1(9%)
Results Posted
67%(2 trials)
Terminated
3(27%)

Phase Distribution

Ph not_applicable
9
82%
Ph phase_4
1
9%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution10 total trials
Phase 4Post-market surveillance
1(10.0%)
N/ANon-phased studies
9(90.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

3 of 6 finished

Non-Completion Rate

50.0%

3 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(1)
Completed(3)
Terminated(3)
Other(4)

Detailed Status

unknown4
Terminated3
Completed3
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
50.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (10.0%)
N/A9 (90.0%)

Trials by Status

recruiting19%
terminated327%
unknown436%
completed327%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
OTHER
Total Trials
11